Published:
|
|
Is there any treatment?
As yet, no specific treatment is known that can halt or reverse the symptoms of Batten disease. However, seizures can sometimes
be reduced or controlled with anticonvulsant drugs, and other medical problems can be treated appropriately as they arise.
Physical therapy and occupational therapy may help patients retain functioning as long as possible.
What is the prognosis?
Over time, affected children suffer mental impairment, worsening seizures, and progressive loss of sight and motor skills.
Eventually, children with Batten disease become blind, bedridden, and demented. Batten disease is often fatal by the late
teens or twenties.
What research is being done?
The biochemical defects that underlie several NCLs have recently been discovered. An enzyme called palmitoyl-protein thioesterase
has been shown to be insufficiently active in the infantile form of Batten disease (this condition is now referred to as CLN1).
In the late infantile form (CLN2), a deficiency of an acid protease, an enzyme that hydrolyzes proteins, has been found as
the cause of this condition. A mutated gene has been identified in juvenile Batten disease (CLN3), but the protein for which
this gene codes has not been identified. In addition, research scientists are working with NCL animal models to improve understanding
and treatment of these disorders. One research team, for example, is testing the usefulness of bone marrow transplantation
in a sheep model, while other investigators are working to develop mouse models. Mouse models will make it easier for scientists
to study the genetics of these diseases.
Synonyms: Neuronal Ceroid Lipofuscinosis